Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.960
+0.120 (4.21%)
Dec 3, 2024, 1:42 PM EST - Market open
Genelux Employees
Genelux had 23 employees as of December 31, 2023. The number of employees increased by 8 or 53.33% compared to the previous year.
Employees
23
Change (1Y)
8
Growth (1Y)
53.33%
Revenue / Employee
$348
Profits / Employee
-$1,202,609
Market Cap
100.95M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 23 | 8 | 53.33% |
Dec 31, 2022 | 15 | - | - |
Related Stocks
Company Name | Employees |
---|---|
23andMe Holding Co. | 582 |
EDAP TMS | 307 |
MDxHealth | 300 |
Adicet Bio | 143 |
Allakos | 131 |
HilleVax | 90 |
Quince Therapeutics | 32 |
Relmada Therapeutics | 20 |
GNLX News
- 26 days ago - Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference - GlobeNewsWire
- 4 weeks ago - Genelux: 2nd Half Of 2025 PRROC Data Is Major Inflection Point - Seeking Alpha
- 5 weeks ago - Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer - GlobeNewsWire
- 7 weeks ago - Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 3 months ago - Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference - GlobeNewsWire
- 3 months ago - Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates - GlobeNewsWire
- 4 months ago - Genelux Corporation to Participate in Fireside Chat at BTIG's Virtual Biotechnology Conference 2024 - GlobeNewsWire
- 6 months ago - Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants - GlobeNewsWire